tiprankstipranks
Advertisement
Advertisement
Private Markets: Bezos’ Prometheus raises $12B as OpenAI files for IPO
PremiumThe FlyPrivate Markets: Bezos’ Prometheus raises $12B as OpenAI files for IPO
1M ago
Cathie Wood Sells $12.3M in Archer Aviation Stock (ACHR). Here Are Her Latest Trades
Premium
Market News
Cathie Wood Sells $12.3M in Archer Aviation Stock (ACHR). Here Are Her Latest Trades
1M ago
Beam Stockholders Back Board, Leadership at Annual Meeting
Premium
Company Announcements
Beam Stockholders Back Board, Leadership at Annual Meeting
1M ago
Analyst Maintains Buy on Beam Therapeutics, Reiterates $75 Price Target Amid Pipeline Progress and De-Risking Milestones
PremiumRatingsAnalyst Maintains Buy on Beam Therapeutics, Reiterates $75 Price Target Amid Pipeline Progress and De-Risking Milestones
2M ago
JonesResearch upgrades ‘fast-follower’ Korro Bio to Buy
Premium
The Fly
JonesResearch upgrades ‘fast-follower’ Korro Bio to Buy
3M ago
Beam Therapeutics reports Q1 EPS (91c), consensus ($1.01)
Premium
The Fly
Beam Therapeutics reports Q1 EPS (91c), consensus ($1.01)
3M ago
Beam Therapeutics price target raised to $68 from $64 at Citi
PremiumThe FlyBeam Therapeutics price target raised to $68 from $64 at Citi
4M ago
Clear Street sees buying opportunity for Beam Therapeutics after study update
Premium
The Fly
Clear Street sees buying opportunity for Beam Therapeutics after study update
4M ago
Beam Therapeutics: BEAM-302’s Differentiated AATD Profile and Accelerated Path Support Buy Rating and $80 Target
Premium
Ratings
Beam Therapeutics: BEAM-302’s Differentiated AATD Profile and Accelerated Path Support Buy Rating and $80 Target
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100